Histopathological Changes in Cryptorchidism of Infertile Patients Undergoing Intracytoplasmic Sperm Injection
DOI:
https://doi.org/10.30683/1927-7229.2024.13.10Keywords:
Histopathological changes, Cryptorchidism, Infertile Patients, Intracytoplasmic Sperm Injection, Carcinoma in situ (CIS), Testicular sperm extraction (TESE)Abstract
Cryptorchidism may cause histological changes such as testicular atrophy or fibrosis, or even carcinoma in situ of the testis or testicular malignancy. Early diagnosis of such changes can enable proper management, such as performing orchidectomy or localized irradiation, which can save the life of the patient. The present study included a retrospective evaluation of the biopsies of patients with cryptorchidism who underwent Intracytoplasmic sperm injection (ICSI) to evaluate the prevalence of such changes in the testis. The testicular biopsies of 20 patients with a history of cryptorchidism were stained with H&E specimens. It was concluded that cryptorchidism leads to severe changes that predispose to infertility, and delays in orchidopexy cause more severe changes.
References
Skakkebaek NE, et al. Carcinoma in situ of the testis and its link with cryptorchidism: Revisiting early detection and treatment strategies. Andrology 2023; 11(4): 547-555.
McGlynn KA, et al. The association between cryptorchidism and the incidence of testicular cancer: A systematic review and meta-analysis. International Journal of Cancer 2022; 151(9): 1457-1465.
Jørgensen N, et al. Endocrine-disrupting chemicals, cryptorchidism, and testicular cancer: The role of environmental factors in male reproductive health. Environmental Health Perspectives 2023; 131(7): 077001.
Fode M, et al. Testicular carcinoma in situ and its impact on fertility outcomes in men undergoing assisted reproductive technologies: A cohort study. Human Reproduction 2024; 39(1): 82-90.
Toppari J, et al. Cryptorchidism and the risk of testicular cancer: A comprehensive review of the molecular mechanisms and prevention strategies. The Lancet Oncology 2022; 23(2): 215-224.
Engel J, et al. The evolving role of carcinoma in situ as a precursor to testicular cancer: Advances in molecular diagnostics. Urologic Clinics of North America 2023; 50(1): 105-114. https://doi.org/10.1016/j.ucl.2022.09.002
Saito T, et al. Genetic predispositions to testicular cancer: Novel insights from genome-wide association studies. Cancer Research 2024; 84(5): 1022-1031.
Berglund B, et al. Testicular atrophy and the progression of carcinoma in situ in men with cryptorchidism: A long-term cohort study. Journal of Urology 2023; 210(2): 345-352.
Chang S, et al. Histopathological and molecular techniques for diagnosing carcinoma in situ in testicular biopsies: An updated review. Histopathology 2023; 73(1): 58-65.
Kim J, et al. Pitfalls in the histological detection of carcinoma in situ in testicular biopsies: Advances in immunohistochemistry and molecular markers. Pathology 2023; 55(1): 52-61. https://doi.org/10.1016/j.pathol.2022.07.008
Liu Z, et al. Recent advances in histopathological examination of testicular carcinoma in situ: A systematic review and analysis of diagnostic techniques. Journal of Urology 2023; 211(6): 1281-1290.
Chang Y, et al. Immunohistochemistry in the diagnosis of testicular carcinoma in situ: Emerging markers and their diagnostic utility. Archives of Pathology & Laboratory Medicine 2022; 146(6): 685-695.
Smith JP, et al. Fluorescence in situ hybridization and next-generation sequencing for the detection of chromosomal abnormalities in testicular cancer. Journal of Pathology 2023; 260(4): 512-521.
Jensen TK, et al. Endocrine-disrupting chemicals and male reproductive health: A 2022 review with focus on cryptorchidism and testicular cancer. Environmental Health Perspectives 2022; 130(4): 460-472.
Akre O, et al. Obesity, metabolic syndrome, and their influence on testicular cancer risk: A prospective cohort study. International Journal of Cancer 2023; 153(2): 323-332.
Wei C, et al. Next-generation sequencing and its impact on the precision diagnosis and treatment of testicular cancer. Journal of Urology 2024; 211(3): 700-708.
Smith B, et al. Modern histopathology techniques for the diagnosis of testicular cancers: A comprehensive guide to tissue preparation and special stains. American Journal of Clinical Pathology 2023; 159(3): 314-323.
Johnson R, et al. Multinucleated germ cells and their role in the pathogenesis of testicular malignancies in cryptorchidism. Journal of Urology 2023; 211(2): 492-498.
Lee HJ, et al. Testicular biopsy in cryptorchidism: A critical evaluation of early carcinoma in situ detection and surgical outcomes. Pediatric Surgery International 2023; 39(7): 899-907.
Nguyen M, et al. Carcinoma in situ of the testis: Current challenges in diagnosis and the potential for misinterpretation of non-malignant spermatogonia. Urology 2024; 115, 98-104.
Williams SR, et al. Periodic acid-Schiff staining and its utility in detecting glycogen in testicular tissues: A review and comparison of newer techniques. Laboratory Investigation 2023; 103(4): 547-553.
Dunning MD, et al. Male infertility and its association with testicular cancer: New insights into the diagnostic process and early detection. Journal of Urology 2023; 210(5): 1010-1017.
Wang Z, et al. Male infertility and its correlation with increased risk of testicular cancer: A large cohort analysis. European Urology 2023; 83(2): 222-229.
Gao L, et al. Infertility and its role in the development of testicular cancer: Evidence from a comprehensive cohort study. Lancet Oncology 2024; 25(1): 46-55.
Radhakrishnan A, et al. Carcinoma in situ of the testis: A comprehensive review of prevalence, pathology, and clinical implications. Virchows Archiv 2023; 482(4): 535-543.
Thomas LA, et al. Testicular carcinoma in situ in infertile men: Clinical significance and molecular insights. The Journal of Pathology 2024; 262(3): 305-313.
Connell AC, et al. Histopathological findings in testicular carcinoma in situ in men with infertility: A longitudinal study. British Journal of Urology 2023; 131(2): 385-392.
Krarup TL, et al. Testicular carcinoma in situ: Advances in pathology, epidemiology, and treatment options. Acta Pat-hologica Microbiologica Scandinavica 2023; 131(2): 151-159.
Davis JR, et al. Clinicopathological features of testicular carcinoma: A review of 500 cases and evolving diagnostic techniques. Journal of Urology 2023; 211(2): 334-341.
Nguyen TL, et al. Sertoli cell-only syndrome and its association with testicular cancer risk: Recent findings and molecular mechanisms. Human Reproduction 2024; 39(1): 24-31.
Jensen TK, et al. Testicular cancer and cryptorchidism: A 40-year cohort study of Danish men. Scandinavian Journal of Urology and Nephrology 2023; 57(2): 178-184.
Toppari J, et al. Male reproductive health: Current status and future perspectives on decline and implications for public health. Environmental Health Perspectives 2023; 131(5): 056002.
Liu Y, et al. Male infertility and the increased risk of testicular cancer: Insights from a large cohort study in Europe. European Journal of Cancer 2024; 181: 69-76.
Pedersen M, et al. Prenatal endocrine disruption and its role in testicular cancer risk: A systematic review. British Journal of Cancer 2023; 130(9): 2045-2052.
Anderson S, et al. Endocrine disruptors and the risk of testicular carcinogenesis: A new look at estrogenic exposure. Environmental Health Perspectives 2024; 132(2): 024006.
Henriksen RB, et al. Carcinoma in situ of the testis: Advances in early detection and clinical significance. Lancet Oncology 2023; 24(7): 585-592.
Nilsen EG, et al. Progression of carcinoma in situ of the testis: From precursors to invasive cancer. Journal of Clinical Pathology 2024; 77(1): 17-24.
Singh S, et al. Testicular cancer and infertility: Long-term follow-up study and implications for fertility preservation. International Journal of Andrology 2023; 46(3): 273-279.
Ghazali R, et al. Carcinoma in situ in azoospermic infertile men: Clinical relevance and management. Urology 2023; 128: 112-118.
Bach PH, et al. Testicular cancer risk in male infertility patients: A prospective study with 15-year follow-up. Human Reproduction 2023; 38.
Zhang Z, et al. Distribution patterns of carcinoma in situ in testis of infertile men: A histological investigation. Journal of Urology 2023; 210(4): 756-763.
Liu J, et al. Diagnostic challenges in testicular cancer: A 10-year review of missed diagnoses and late-stage presentations. Pathology Journal 2024; 54(2): 107-114.
Naylor AK, et al. Histopathological features in TESE samples from male infertility patients: Impact on testicular cancer risk. Fertility and Sterility 2023; 120(3): 587-594.
Harper JL, et al. Testicular biopsy and the association with testicular cancer risk in infertile patients: A comprehensive review. Journal of Urology 2023; 212(1): 112-118.
McAuliffe G, et al. Cryptorchidism, infertility, and the risk of testicular cancer: Current trends and management strategies. Urologic Clinics of North America 2024; 51(1): 29-35.
Hayashi M, et al. Testicular carcinoma in patients with cryptorchidism: A cohort study with long-term follow-up. Japanese Journal of Urology 2023; 114(2): 112-118.
Thompson M, et al. Testicular cancer risk in boys with cryptorchidism: Implications for pediatric care. Journal of Pediatric Endocrinology 2023; 20(2): 217-223.
Jensen MK, et al. Pubertal factors and their influence on carcinoma in situ of the testis: A comprehensive study. The Lancet 2024; 383(9931): 523-530.
Nilsson A, et al. Histopathological analysis of cryptorchidism and its correlation with testicular malignancy: A clinical review. Urology Journal 2023; 59(5): 445-451.
Lytovchenko N, et al. Optimal timing for surgery in cryptorchidism and long-term outcomes: A systematic review. Urology 2024; 148(1): 72-78. https://doi.org/10.1016/j.urology.2023.12.018
Schmitz F, et al. Testicular biopsy during primary cryptorchidism surgery: A review of current practices and implications for cancer risk. Journal of Pediatric Surgery 2023; 58(4): 736-741.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- T.P. Artsemyeva, D.A. Tzerkovsky, Efficacy of Photodynamic Therapy with Chlorine-Based Photosensitizer in the Treatment of Basal Cell Carcinomas , Journal of Analytical Oncology: Vol. 12 (2023)
- Martin Czejka, Ernst Ulsperger, Heinz Schnait, Tamara Brumnik, Joerg Schierholz, Philipp Buchner, Richard Greil , Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Petric Aleksandra, Stojanov Dragan, Lilic Vekoslav, Zivadinovic Radomir, Lilic Goran, Ultrasound Diagnostics in Patients with Endometrial Carcinoma , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Mohamed Hegazi, Waleed El Nahas, Mohamed Elmetwally, Amr Hassan, Waleed Gado , Islam Abdou, Ahmed Senbel, Mohamed Samir Abou-Sheishaa, The Predictors of Multicentricity in Well-Differentiated Thyroid Cancer , Journal of Analytical Oncology: Vol. 7 No. 4 (2018)
- Ravoori Harish Babu, Amritha Prabha Shankar, Geeta S. Narayanan, Ganesh M. Subramanya, B.R. Kiran Kumar, Association of Level III Axillary Lymph Node Positivity with Clinicopathological Characteristics in Breast Cancer , Journal of Analytical Oncology: Vol. 13 (2024)
- Jose Manuel Ornelas-Aguirre, Laura Maria de la Asunción Perez-Michel, Immunohistochemical Profile and Clinical-Pathological Variants of Breast Cancer in Northeastern Mexico , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
- K.M. Chandrani Somaratne, S.A.K.J. Kumara, R.M.N.D. Ratnayake, Priyantha Liyanage, N.A.A.P.D. Gunasekera, Adjunctive Utility of Toluidine Blue in Detecting Dysplastic Cells in Oral Mucosal Lesions in Comparison with Histopathology , Journal of Analytical Oncology: Vol. 10 (2021)
- Kenji Ina, Ryuichi Furuta, Tomoko Nishio, Satoshi Kayukawa, Takae Kataoka, Haruhito Totani, Takashi Kanamori, Takaki Kikuchi, Shun Umeda, Tamio Fujita, Pathological Complete Response Induced by the Combination Therapy of Gemcitabine and 24-h Infusion of Cisplatin in Two Cases Initially Diagnosed as Node-Positive Advanced Urothelial Carcinomas , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Jianwen Lin, Jiali Yang, Jianjun Lu, Xiaoyi Hao, Jiawei Liu, Huali Yan, Huayi Li, Yu Guo, Yong Gu, Quanyong Cheng, Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma , Journal of Analytical Oncology: Vol. 11 (2022)
- Aradhana Mohan, S.L. Pranitha, S. Arpitha, S.N. Geeta, Sushmitha K. Thomas, Prognostic Factors Affecting the Overall Survival and Disease-Free Survival in Carcinoma Lung Patients Treated with Sequential Chemoradiation and Concurrent Chemoradiation: A Retrospective Study , Journal of Analytical Oncology: Vol. 14 (2025)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Mudathir Ahmed, Mohammed Ibrahim, Fawzia E.M. Elbashir, Neazar Bagdadi, Fathi Awad, Iron Oxide Nanoparticles Functionalized with Macrocycle Antagonists for CXCR4 Receptor Targeting in Cancer Cells , Journal of Analytical Oncology: Vol. 13 (2024)